(Q34132880)

English

Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Rana Rais

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ming Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ping He

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Linping Xu

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

John F Deeken

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michelle A Rudek

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Biomedical Chromatography

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1315-1324

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

Sunitinib: from rational design to clinical efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

Role of tyrosine kinase inhibitors in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

Measurement of fraction unbound paclitaxel in human plasma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

Ultrafiltration in serum protein binding determinations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

5 July 2018

A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

28 October 2018

Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

28 October 2018

The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

28 October 2018

Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382044

28 October 2018

Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22259028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance frontal analysis for drug-protein binding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22259028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance capillary electrophoresis/frontal analysis for the study of protein binding of a basic drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/22259028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib maleate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22259028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC-MS/MS

1 reference

https://pubmed.ncbi.nlm.nih.gov/22259028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22259028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/BMC.2697

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34132880&oldid=2144926894"